SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Amedica Corporation on May 26, 2016. The filing details the voting results for three specific proposals submitted to shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
Three proposals were voted upon at the Annual Meeting:
- Proposal No. 1 (Director Election): Stockholders elected two Class II directors for a three-year term.
- David W. Truetzel: Approved (2,243,723 For vs. 681,439 Withheld).
- Eric Stookey: Approved (2,043,436 For vs. 881,726 Withheld).
- Proposal No. 2 (Equity Plan Amendment): Approved an amendment to the 2012 Equity Incentive Plan, increasing authorized shares by 800,000 to a total of 1,142,425 shares.
- Vote Count: 1,632,955 For vs. 1,264,851 Against.
- Proposal No. 3 (Auditor Ratification): Ratified the appointment of Mantyla McReynolds LLC as the independent registered public accounting firm for the year ending December 31, 2016.
- Vote Count: 7,038,096 For vs. 386,906 Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of the shareholder vote results.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Confirm the impact of the 800,000 share increase on the 2012 Equity Incentive Plan on future dilution.
- Review the full proxy statement for detailed biographies of the newly elected directors.
- Check subsequent filings for the company's financial performance, as this 8-K contains no financial data.